Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group
Launched by UNIVERSITY OF RHODE ISLAND · May 2, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a special program to help people from a First Nation community who want to cut down or stop using alcohol. The program will take into account their unique cultural background and experiences of trauma, especially historical trauma that affects their community. The research team will work closely with community members to understand their needs and gather information that will help develop this program. They will also test the program to see how well it works and if people find it acceptable compared to those who are not receiving the program.
To be part of this trial, participants need to be at least 18 years old, have used alcohol in the past week, identify as a member of the First Nation, and live in the community involved in the study. They should also be motivated to reduce or stop their alcohol use. However, people experiencing severe mental health issues, like psychosis, or those at high risk of alcohol withdrawal will not be eligible. This study is important because it aims to improve health outcomes for Indigenous populations by addressing alcohol use in a culturally sensitive way.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years of age
- • Used alcohol in the past week
- • Self-identify as a First Nation member
- • Reside within the partner community
- • Want to cut down or stop alcohol use
- Exclusion Criteria:
- • Experiencing current psychotic symptoms
- • High scores (\>10) on the Clinical Institute Withdrawal Assessment for Alcohol, Revised
About University Of Rhode Island
The University of Rhode Island (URI) is a leading academic institution dedicated to advancing research and innovation in health sciences. With a strong commitment to enhancing public health through rigorous clinical trials, URI leverages its multidisciplinary expertise and state-of-the-art facilities to conduct high-quality research. The university fosters collaboration among faculty, students, and healthcare professionals to address pressing medical challenges and improve patient outcomes. By promoting a culture of inquiry and scientific exploration, URI plays a pivotal role in translating research findings into practical applications that benefit communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fredericton, New Brunswick, Canada
Patients applied
Trial Officials
Nichea S Spillane, Ph.D.
Principal Investigator
University of Rhode Island
Nicole H Weiss, Ph.D.
Principal Investigator
University of Rhode Island
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials